|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current assets | |||||||
| Cash | |||||||
| Prepaid expenses | |||||||
| Total Current Assets | |||||||
| Investments held in Trust Account | |||||||
| TOTAL ASSETS | |||||||
| LIABILITIES, COMMITMENTS AND CONTINGENCIES AND SHAREHOLDERS' DEFICIT | |||||||
| Current liabilities | |||||||
| Accounts payable and accrued expenses | |||||||
| Accrued expenses | |||||||
| Working capital note — related party | |||||||
| Total Current Liabilities | |||||||
| Warrant Liabilities | |||||||
| Deferred underwriting fee payable | |||||||
| Total Liabilities | |||||||
| Class A ordinary shares subject to possible redemption, 40,845,476 shares at $10.07 and $10.00 per share at September 30, 2022 and December 31, 2021, respectively | |||||||
| Shareholders' Deficit | |||||||
| Preference shares, $0.0001 par value; 1,000,000 shares authorized; no shares issued or outstanding | |||||||
| Ordinary shares | |||||||
| Common Class A | |||||||
| Common Class B | |||||||
| Additional paid-in capital | |||||||
| Accumulated deficit | |||||||
| Total Shareholders' Deficit | |||||||
| TOTAL LIABILITIES, COMMITMENTS AND CONTINGENCIES AND SHAREHOLDERS' DEFICIT |
Loading...